These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23526771)

  • 1. Pretherapeutic MRI for decision-making regarding selective neoadjuvant radiochemotherapy for rectal carcinoma: interim analysis of a multicentric prospective observational study.
    Ptok H; Ruppert R; Stassburg J; Maurer CA; Oberholzer K; Junginger T; Merkel S; Hermanek P
    J Magn Reson Imaging; 2013 May; 37(5):1122-8. PubMed ID: 23526771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study.
    Strassburg J; Ruppert R; Ptok H; Maurer C; Junginger T; Merkel S; Hermanek P
    Ann Surg Oncol; 2011 Oct; 18(10):2790-9. PubMed ID: 21509631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.
    Oberholzer K; Menig M; Pohlmann A; Junginger T; Heintz A; Kreft A; Hansen T; Schneider A; Lollert A; Schmidberger H; Christoph D
    J Magn Reson Imaging; 2013 Jul; 38(1):119-26. PubMed ID: 23188618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
    J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological short-term effects and adverse events of MRI-guided selective neoadjuvant radiochemotherapy for rectal cancer.
    Maurer CA; Mattiello D; Duwe J; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
    Anticancer Res; 2012 May; 32(5):1721-8. PubMed ID: 22593452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spincter preservation after selective chemoradiotherapy of rectal cancer. Interim results of the OCUM study].
    Baral J; Schön MR; Ruppert R; Ptok H; Strassburg J; Brosi P; Kreis ME; Lewin A; Sauer J; Sawicki S; Schiffmann L; Winde G; Junginger T; Merkel S; Hermanek P
    Chirurg; 2015 Dec; 86(12):1138-44. PubMed ID: 26347011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.
    Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A
    Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
    Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.
    Kulkarni T; Gollins S; Maw A; Hobson P; Byrne R; Widdowson D
    Colorectal Dis; 2008 Jun; 10(5):479-89. PubMed ID: 18318754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.
    Wieder HA; Rosenberg R; Lordick F; Geinitz H; Beer A; Becker K; Woertler K; Dobritz M; Siewert JR; Rummeny EJ; Stollfuss JC
    Radiology; 2007 Jun; 243(3):744-51. PubMed ID: 17463134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The circumferential resection margin in rectal carcinoma surgery.
    Hermanek P; Junginger T
    Tech Coloproctol; 2005 Dec; 9(3):193-9; discussion 199-200. PubMed ID: 16328130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal Cancer: MR imaging of the mesorectal fascia and effect of chemoradiation on assessment of tumor involvement.
    Oberholzer K; Junginger T; Heintz A; Kreft A; Hansen T; Lollert A; Ebert M; Düber C
    J Magn Reson Imaging; 2012 Sep; 36(3):658-63. PubMed ID: 22592948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma.
    Gosens MJ; Klaassen RA; Tan-Go I; Rutten HJ; Martijn H; van den Brule AJ; Nieuwenhuijzen GA; van Krieken JH; Nagtegaal ID
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6617-23. PubMed ID: 18006762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer.
    Suppiah A; Hunter IA; Cowley J; Garimella V; Cast J; Hartley JE; Monson JR
    Colorectal Dis; 2009 Mar; 11(3):249-53. PubMed ID: 18513192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.
    Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J
    J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2.
    Rullier A; Gourgou-Bourgade S; Jarlier M; Bibeau F; Chassagne-Clément C; Hennequin C; Tisseau L; Leroux A; Ettore F; Peoc'h M; Diebold MA; Robin YM; Kleinclaus I; Mineur L; Petitjean C; Mosnier JF; Soubeyran I; Padilla N; Lemaistre AI; Bérille J; Denis B; Conroy T; Gérard JP
    Eur J Cancer; 2013 Jan; 49(1):82-9. PubMed ID: 22909998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Accuracy of preoperative magnetic resonance imaging in prediction of pathological stage and circumferential resection margin in rectal cancer].
    Jiang JB; Dai Y; Zhang XM; Li CF; Jin ZT; Bi DS; Sun JZ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):961-4. PubMed ID: 16759535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
    Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.